Related Experiment Videos
Progeria: a human-disease model of accelerated aging
1Department of Human Genetics, New York State Institute for Basic Research, Staten Island 10314.
The American Journal of Clinical Nutrition
|June 1, 1992
Summary
Progeria, a rare genetic disease causing rapid aging, may stem from a sporadic dominant mutation. Elevated hyaluronic acid (HA) and potential bioinactive growth hormone (GH) are implicated in patient growth failure.
Area of Science:
- Genetics
- Endocrinology
- Aging Research
Background:
- Progeria is a rare genetic disorder characterized by features resembling accelerated aging.
- Its inheritance pattern suggests a sporadic dominant mutation.
- Patients often exhibit elevated hyaluronic acid (HA) excretion.
Purpose of the Study:
- To investigate the underlying causes of failure to thrive in progeria patients.
- To explore the roles of growth hormone (GH) and hyaluronic acid (HA) in progeria.
- To identify potential therapeutic targets for progeria.
Main Methods:
- Observation of progeria patients' clinical features and biochemical markers.
- Analysis of growth hormone (GH) and insulin-like growth factor I (IGF-I) levels.
- Assessment of basal metabolic rates (BMRs) before and after GH treatment.
Main Results:
- Progeria patients showed normal GH but low IGF-I levels, with high BMRs.
- GH treatment led to increased linear growth and a decreased BMR in two patients.
- Elevated HA levels were observed in progeria patients.
Conclusions:
- Progeria's failure to thrive may be linked to bioinactive GH and impaired vasculogenesis due to excess HA.
- Understanding the progeria mutation could illuminate key genes in normal aging processes.
- Further research into GH and HA pathways is warranted for progeria treatment.